Pivotal bioVenture Partners Investment Advisor’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.4M | Buy |
|
|||||
|
2025
Q1 | $26.8M | Buy |
|
|||||
|
2024
Q4 | $57.6M | Buy |
|
|||||
|
2024
Q3 | $73.1M | Sell |
|
|||||
|
2024
Q2 | $59.9M | Hold |
|
|||||
|
2024
Q1 | $54.2M | Hold |
|
|||||
|
2023
Q4 | $49.8M | Hold |
|
|||||
|
2023
Q3 | $40.4M | Hold |
|
|||||
|
2023
Q2 | $39.6M | Buy |
|
|||||
|
2023
Q1 | $26M | Hold |
|
|||||
|
2022
Q4 | $33.2M | Sell |
|
|||||
|
2022
Q3 | $18.6M | Sell |
|
|||||
|
2022
Q2 | $18.1M | Sell |
|
|||||
|
2022
Q1 | $26.8M | Hold |
|
|||||
|
2021
Q4 | $26.4M | Sell |
|
|||||
|
2021
Q3 | $35.7M | Hold |
|
|||||
|
2021
Q2 | $31.6M | Hold |
|
|||||
|
2021
Q1 | $27.8M | Sell |
|
|||||
|
2020
Q4 | $59.1M | Buy |
|